1

Thomas Andrew Gaziano

Date Prepared: June 12, 2018

Name: Thomas Andrew Gaziano

Office Address: Brigham and Women’s Hospital

Cardiovascular Medicine Division

75 Francis Street

Boston, MA 02115

United States of America

Center for Health Decision Science

Harvard School of Public Health

718 Huntington Avenue, Room 206

Boston, MA 02115-5924

United States of America

Home Address: 32 Kelveden Road

Waban, MA 02468

United States of America

Work Phone: (617) 525-7526

(617) 432-4348

Work Email: tgaziano@bwh.harvard.edu

Work FAX: (617) 432-0190

Place of Birth:

Morgantown, WV

Education

1990 B.A. (Summa cum laude) Chemistry West Virginia University,

Morgantown, WV

1992 B.A. (Hons) Philosophy, Politics,

Economics

Oxford University, Oxford,

England

1996 M.D. (Cum laude) Medicine Harvard Medical School,

Boston, MA

2002 M.Sc. Health Policy and

Management

Harvard School of Public

Health, Boston, MA

2

Postdoctoral Training

07/96-06/97 Intern Internal Medicine Brigham and Women’s

Hospital (BWH), Boston, MA

07/97-06/99 Resident Internal Medicine BWH

09/99-06/00 Lancet International

Fellow

International Epidemiology Groote Schuur Hospital,

University of Cape Town

(UCT), South Africa

07/00-06/03 Clinical Research Fellow Cardiovascular Disease BWH

07/01-06/02 Agency for Healthcare

Research and Quality

(AHRQ) National

Research Service Award

Trainee

Health Policy Harvard TH Chan School of

Public Health (HSPH)

09/17-05/18 Fellow BWH Leadership

Management Training

Harvard Business School

Faculty Academic Appointments

07/03- 03/08 Instructor Medicine Harvard Medical School

(HMS)

04/08-present Assistant Professor Medicine HMS

12/08-present Assistant Professor Health Policy and

Management (HPM)

HSPH

Appointments at Hospitals/Affiliated Institutions

07/03-present Associate Physician Department of Medicine BWH

10/16-present Physician Department of Medicine Spaulding Hospital Cambridge

Other Professional Positions

2007-09 Honorary Senior Lecturer Department of Medicine,

UCT

2013-14

Chief Medical Officer, Executive Vice-President Accountable Care

Associates, Inc. Springfield,

MA

2013-14

Medical Director, Accountable Care Organization-

Achieved $10 million (5% savings) in surplus for 2013

& 100% ACO quality reporting score-Track 1 MSSP

Accountable Care Clinical

Services, 1776. Springfield,

MA

3

2014-present

International Committee Member, Health Assessment,

Monitoring and Intervention Board (HAMI), Vitality

International Epidemiology and Clinical Advisory Board

Vitality Institute, Discovery

Health Care, South Africa

Major Administrative Leadership Positions

Local

2007-14 Co-Chair, Cardiovascular and Pulmonary Disease

Working Group

Harvard T.H. Chan School of

Public Health, Center for

Health Decision Science

2008-14 Co-Director, Chronic and Cardiovascular Diseases

Working Group

Harvard University, Harvard

Global Health Institute

2015-present Director, Global CVD Health Policy and Prevention

Unit

Brigham and Women’s

Hospital, Cardiovascular

Medicine Division

2015-present Committee Member, American Heart Association

(AHA) National Committee: Epidemiologic Mission

on Metrics.

American Heart Association

2016-present Director, Spaulding Hospital Cambridge

Cardiovascular Consultation Service

Spaulding Hospital

Cambridge, Dept of Medicine

2016-present Director, Strategic Planning, CV Division Brigham & Women’s Hospital

Cardiovascular Medicine

Division

International

2010-present Executive Committee Member, Center for Chronic

Disease Institution of Africa (CDIA)

National Heart, Lung and

Blood Institute (NHLBI)

Center of Excellence, UCT

2016-present Chair, Representing the American College of

Cardiology to The Partners Council of The World

Heart Federation (WHF)

American College of

Cardiology, Washington DC

and The World Heart

Federation (WHF), Geneva,

Switzerland.

2017-present Board Member, World Heart Federation World Heart Federation,

Geneva Switzerland

4

Committee Service Local

2009 Cardiovascular Disease in Developing Countries –

Moving Forward

Harvard Global Health Institute,

Harvard University

Host

National 2007 NHLBI Director’s Expert Panel on Global

Cardiovascular Disease Research

National Institutes of Health

(NIH), Bethesda, MD

Member

2007 NHLBI Global Cardiovascular Health Thought Leaders

Meeting Panel

NIH

2009- 2013 NHLBI Expert Panel on Integrated Cardiovascular

Disease Risk Reduction in Adults

NIH

2009- 2013 NHLBI Guidelines Implementation Work Group NIH

2018 ACC Prevention Section ACC

International

2006-2009 Macroeconomics Study of Cardiovascular Disease in

Developing Countries

World Bank and the Initiative

for Cardiovascular Health in

Developing Countries, New

Delhi, India

Member

2007 Expert Panel for Community Interventions for Health Oxford Health Alliance, Greater

London, UK

Member

2011 Economic Burden of NCDs. World Economic Forum. CVD Section Leader

2012- present WHF Scientific And Policy Initiatives Committee:

Research Working Group

Member

2013 WHF Abstract reviewer for 2014 World Congress of

Cardiology

Participant

2018 Examiner for Mandy Maredza’s Doctor of Philosophy

thesis

WITS University

Professional Societies

1992-2000 Massachusetts Medical Society

1992-2000

Member

2000- American Heart Association

2000-2006

2008

Member

Member, Joint Conference. 49th

Cardiovascular Disease

Epidemiology and Prevention –

and- Nutrition, Physical Activity,

5

and Metabolism Abstract Review

Panel

2000- American College of Cardiology

2000-present

2012

2016-present

Member

Abstracts Reviewer

Fellow

2007 Asian Pacific Congress of Hypertension

2007

Co-Chair, Session on the Social

and Economic Burden of

Hypertension. 9th International

Symposium on Hypertension and

Related Diseases

Grant Review Activities

2009 - 2010 NIH Center for Scientific Review Special Emphasis Panel;

PAR-08-175: Millennium Promise Awards: Non-

communicable Disease.

2009

2010

NIH

Ad hoc Member

Ad hoc Member

Editorial Activities Ad hoc Reviewer

Circulation

Circulation Heart Failure

The Lancet

Value in Health

Health Affairs

Journal of the American College of

Cardiology

Journal of the American Medical Association

New England Journal of Medicine

BioMed Central

Journal of Clinical Epidemiology

Other Editorial Roles

2011- present Deputy Editor Global Heart

2012- present Volume, Co-Editor Disease Control Priorities:

Cardiovascular Disease

2015, 2016 Special Editor Current Cardiology Reports

6

Honors and Prizes

1990 Phi Beta Kappa West Virginia University

1990 Rhodes Scholarship Oxford University, England

1995 Massachusetts Medical Society Scholars Award Massachusetts Medical

Society

1999 Lancet International Fellowship The Lancet

2001 Abstract Poster Finalist AHA Annual Meeting

2001 National Research Service Award Fellowship HSPH

2001 Eugene Braunwald Named Fellowship Cardiovascular Division,

BWH; HMS

2001 Prize for Original Research Presentation South African Hypertension

Society

2003 ACC/Bristol Myers Squibb Affiliate Travel Award 52nd Annual Scientific

Session, American College of

Cardiology

2006 Chosen Fellow for 39th Ten Day International

Teaching Seminar on Cardiovascular Disease

Epidemiology and Prevention, International CVD

World Heart Federation

(WHF), Brisbane, Australia

2010 Professor Jeremy Knowles Scholar Harvard University

2011, 2012 BWH Faculty Mentor Award,, Chosen by BWH

Medical Residency Program

BWH

2014 BWH Brigham Way Recipient for patient care,

Recognition from BWH President Betsy Nabel, MD

BWH

2014 Fred Epstein Memorial Lecture Recipient European Society of

Cardiology, (EuroPRevent

Meeting)

2016 American College of Cardiology Fellow

2018 Inaugural Duke Global Health Institute Visiting

Professor

Duke University

Report of Funded and Unfunded Projects

Funding Information

Past

7

2004-2006 Integrated cost-effectiveness analyses for cardiovascular disease in the Disease Control

Priorities Project in Developing Countries

N.I.H., 263-MD-416765

P.I.

Conducted, designed and reported on multiple cost effective analyses of interventions for

cardiovascular disease management in developing countries.

2004-2011 Cost-Effective Prevention of Cardiovascular Disease in Developing Countries

N.I.H., 2 K01 TW007141-05

P.I.

Compare lab-based to non-lab based screening analyses for CVD in South Africa and

India.

2006 Lerner Research Young Investigator Award

Foundation/BWH Cardiovascular Medicine Division

P.I.

Conducted and presented research on a cost effective analysis of a multi-drug regimen

for preventing cardiovascular disease.

2006 Young Investigator in Medicine Award

Foundation/BWH Department of Medicine

P.I.

Researched and conducted analysis of a risk assessment strategy for preventing

cardiovascular disease.

2008-2009 Macroeconomic Consequences of Chronic Disease Study Initiative For Cardiovascular

Health

P.I.

Calibrate a non-lab based screening tool for CVD risk prediction in South Africa and

India using cross-sectional data, conduct cost-effectiveness analyses of screening for

CVD, and determine the different costs and benefits associated with various threshold

levels of absolute risk.

2008-2014 Centre of Excellence For Chronic Disease Control in Southern Africa – Development,

Implementation and Evaluation of a Healthcare Delivery Model For Chronic Diseases

in South Africa and Tanzania

N.H.L.B.I., United Health Care, HHSN268200900030C

Co-P.I. [PI: Levitt, NL]

The goal is to promote the development, evaluation, and implementation of an evidence-

based and sustainable multi-faceted model of care that will result in the reduction of the

burden of chronic diseases and risk factors among underserved populations in

Sub-Saharan Africa. Role is to coordinate two of three research projects on non-lab

based risk assessment and cardiovascular disease modeling in South Africa for cost

effectiveness.

2009 Economic Evaluation of Hypertension Awareness, Compliance, and Control.

Institute of Medicine

P.I.

8

Study to evaluate potentials costs of hypertension control in select developing countries

as compared to the United States.

2010-2011 The Economic Consequences of Hypertension Treatment and Potential Benefits from

National Intervention Programs in 25 Developing Countries.

United Health Care/NHLBI Centers of Excellence

PI

The purpose of the project is to give some estimates of the cost of the CVD burden in

countries working together through the NHLBI Centers of Excellence in preparation for

The United Nations General Assembly Meeting on Chronic Diseases

2010-2013 Reducing Cardiovascular Risk Using Novel Incentive Approaches.

NIH/University of Pennsylvania, RC4AG039114-01

Co-Investigator. [PI: Volp, K]

This project will test the effectiveness and cost effectiveness of providing lottery-based

financial incentives to physicians and to physicians in combination with their high risk

patients on reducing CVD risk, as defined by Framingham Risk Score. Only those patients

with very high risk profiles will be enrolled. Alternative financial incentive models will be

compared to a control group of physicians and physicians plus a sample of their high risk

patients, all of which will receive feedback alone. Physicians, as opposed to other health care

providers, are charged with creative problem-solving when treating individual patients; this

project is thus focused on interventions for physician health care providers.

2011-2013 An Evaluation of community health workers screening for CVD in the community in four

NHLBI/United Health Centers of Excellence

UCT, HHSN268200900030C

P.I.

Training community health workers to use a non-lab based risk assessment tool to identify

persons at high risk for cardiovascular diseases in community settings in South Africa,

Bangladesh, Guatemala, and Mexico.

Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment

NHLBI, 1 R01 HL104284-02

P.I.

The purpose of this project is to analyze, synthesize, and integrate the best available data to

develop an integrated Cardiovascular Disease (CVD) Prevention Model that can assess the

most effective and cost-effective means for screening and treating those at moderate to high

risk for CVD.

Comparative-Effectiveness of Population Strategies to Improve Diet and Reduce CVD

NHLBI, 7R01HL115189

Co-I [PI: Mozaffarian, D] ($75,000 direct)

The goals of this study are to evaluate the comparative-effectiveness of evidence-based

population interventions to improve diet and to evaluate the comparative-effectiveness of

population interventions to reduce CVD mortality in the US, using nationally representative

data.

2010-2015

NCE

2015-2016

2014-2017

9

2014-2017

2016-2017

Health and Aging in Africa: Longitudinal Studies of INDEPTH Communities (HAALSI)

NIA, 5P01AG041710-02

Co-I [PI: Berkman, L] ($9,161direct)

The study seeks to examine the social, economic, and health systems that influence the onset

and course of major cardiometabolic disorders and HIV in Africa. Physical and cognitive

functioning in older adults and the productivity, well-being, social and family consequences

of disease are also being studied.

mHealth Interventions to Improve Access and Coverage of Uninsured People with High

Cardiovascular Risk in Argentina

NIH, 1R21TW010173

PI ($263,993 direct)

This study will determine if providing CHWs with an mHealth application using an

integrated, inexpensive and validated screening tool on cell phones for screening in the

community - which is linked with the primary care clinic (PCC) scheduling system

wirelessly, allowing the CHWs to make appointments at the time they identify high-risk

individuals - will increase the number of referral and follow-up visits that patients attend at

the PCCs.

Current

2013-2018 Co-morbidity of AIDS/HIV Affective disorders and Long Term conditions (COBALT)

NHLBI, 1R01MH100470

Co-I [PI: Fairall, L] ($160,000 direct)

The objective of the study is to address an important gap in research evidence for cost-

effective, scalable interventions for HIV positive adults on antiretroviral treatment (ART)

with depression in low resource settings.

2016-2018

Health and Economic Evaluation of a Polypill in Secondary Prevention in the United States

United Health Care

PI ($209,610 direct)

This study is to evaluate the cost-effectiveness of a Polypill in the United States both in a

commercial and Medicare population. We use the CVD PREDICT model designed at BWH

and Harvard School of Public Health.

2016-2020 Economic Analyses of Policy Strategies to Improve Diet and Reduce CVD

NIH, 1R01HL130735-01A1

Co-PI [PI: Micha, R] ($183,860)

The goals of this study are to evaluate the economic effectiveness of population strategies to

improve diet and to evaluate the comparative-effectiveness of population interventions to

reduce CVD mortality in the US, using nationally representative data.

2016-2018 Reimagining Population Health: Development of a Virtual Heart Failure Clinic

Novartis

Co-PI [PI: MacRae, C] ($7,931,484)

10

The goals of this study are to design a heart failure identification algorithm; and then remote

management of patients identified with reduced ejection heart failure, using innovative

techniques in data retrieval, data base learning and compassionate engagement; and the

development of educational material. Cost effective analyses and changes in total medical

expenses will be assessed.

2016-2018

2017-2018

2017-2022

BWH Cardiovascular Division Lipid Optimization (B-LO)

Blue Cross/Blue Shield of Massachusetts

Co-PI [PI: MacRae, C] ($862,000)

The goals of this study are to design a CVD risk algorithm; and then remote management of

patients identified with non-optimal lipid levels, using innovative techniques in data retrieval,

data base learning and compassionate engagement; and the development of educational

material.

Million Hearts CVD Risk Reduction Model

Center for Medicare and Medicaid Services (Mathematica Policy Institute);

HHSM-500-2014-00034I

Co-PI ($57,032 direct) ($90,681 total)

The evaluation will include an implementation study to understand if and how participating

organizations are changing their CVD care for their Medicare fee-for-service beneficiaries in

response to the Million Hearts CVD model’s financial incentives and technical supports. It

will also include a rigorous assessment, building from the model’s cluster randomized design,

of the model’s impact on risk scores, CVD events, and Medicare FFS spending.

National Institute for Ageing (NIA): Health and Aging in Africa: Longitudinal Studies of

INDEPTH Communities (HAALSI).

2.2P01AG041710-04

Co-PI [PI: Berkman] ($205,477 direct) ($364,722 total)

The study seeks to examine the social, economic, and health systems that influence the onset

and course of major cardiometabolic disorders and HIV in Africa. Physical and cognitive

functioning in older adults and the productivity, well-being, social and family consequences

of disease are also being studied.

Projects

Submitted for

Funding:

Pending

Development, Validation, and Application of a Stroke Policy Simulation Model

NIH (NINDS), (R-01,Grant #)

Co-I [PI: Pandya, A] (Direct Costs Requested = $49,237)

The objective of this research is to develop, validate, and apply simulation modeling to

identify cost-effective health policies to prevent and treat stroke.

Pending Epidemiology of coronary artery disease among people with HIV in rural sub-Saharan

Africa

NIH, (R-01,Grant #)

Co-I [PI: Siedner, Mark J] (Direct Costs Requested = $99,484)

11

This study seeks to determine the impact of HIV on CAD in rural Uganda, and identify

regionally-relevant determinants of CAD, with an overarching goal to identify interventions

to improve the health of people living with HIV. A risk prediction score will also be

developed for this population.

Training Grants and Mentored Trainee Grants:

2017 Promoting Capacity Building in Chronic Diseases Research in South America.

NIH/FIC D431W009126

Mentor of Raul Martin Chapparro, MD

The aims of the award are to assist with IECS curriculum and faculty development, to

strengthen the current IECS master’s program by providing extended didactic training at

HSPH to selected students, and the development of a new PhD program at IECS including

year-long mentored training at HSPH.

2017 Fogarty Partnership for Global Health Research Training.

NIH/FIC

The Harvard-BU-Northwestern-UNM provides supportive mentorship, research opportunities

and a collaborative research environment for early stage investigators to enhance their global

health research expertise and their careers. Supported research areas include: HIV/AIDS and

associated co-infections, NCDs including cardiovascular disease and diabetes, mental health,

and maternal child health and nutrition.

Report of Local Teaching and Training

Teaching of Students in Courses

HMS Courses:

2003 AC701.0 Critical Reading of the Medical Literature

Tutor for 8 Medical Students

HMS

Contact time: 2 hours per

week for 11 weeks.

2004 AC701.0 Critical Reading of the Medical Literature

Tutor for 8 Medical Students

HMS

Contact time: 1.5 hours per

week for 10 weeks.

2016 CI 702-Clinical Trials. Session 8:Assessment of Health

Related Quality of Life and Cost Effectiveness.

Guest Lecturer

HMS

Contact time: 1 hours

Other Harvard courses

2008 RDS 282 Cost-Effectiveness Analysis and Cost-Benefit

Analysis in Public Health Medicine.

Session 4: Measuring Health Consequences of CVD in

Developing Countries

Guest Lecturer

HSPH

Contact time: 2 hours

12

2009 RDS 282 Cost-Effectiveness Analysis and Cost-Benefit

Analysis in Public Health Medicine. Session 13:

Models of CVD and CEAs in Developing Countries

Guest Lecturer

HSPH

Contact time: 3 hours

2009 Freshman Seminar 26x: Burden of Cardiovascular

Disease in the Developing World: A Silent Epidemic

Undergraduate Students

Harvard College (HC)

Contact time: 3 hours per

week for 10 weeks

2011 Freshman Seminar 26x: Burden of Cardiovascular

Disease in the Developing World: A Silent Epidemic

Undergraduate Students

HC

Contact time: 3 hours per

week for 10 weeks

2011 SCRB 175 Glucose: From Molecule to Society. “The

changing landscape of global health. The transition from

hunger and diseases of poverty to diseases of the

developed world.”

Guest Lecturer

HC

Contact time: 2 hours

2012 GSAS 3060HF Research Seminars in Decision Science.

Global Cardiovascular Disease: Challenges and

Solutions.

Guest Lecturer

HSPH

Contact time: 2 hours

2013 GSAS 3060HF Research Seminars in Decision Science.

CVD Screening, Absolute Risk, Dichotomous Variables,

Other Challenges in Developing Countries and the

Special Case of Diabetes

Guest Lecturer

HSPH

Contact time: 2 hours

2014 NUT 214 Policies for Global Cardiovascular and

Metabolic Health; Translating Knowledge into Action.

Economic Burden of CVD: Cost-effectiveness of CVD

Interventions

Guest Lecturer

HSPH

Contact time: 2 hours

Formal Teaching of Residents, Clinical Fellows and Research Fellows (post-docs)

2003- present Teaching rounds for residents and clinical fellows in

Cardiology in-patient services

BWH

240 hours/year

Clinical Supervisory and Training Responsibilities

2008- present Supervisor of B-Team Cardiology Series, 1 Resident and

2 Interns

BWH

240 hours/year

Laboratory and Other Research Supervisory and Training Responsibilities

13

2003- present Research Supervision and Attending

1 Fellow

BWH

40 hours/year

2005- present Research Supervisor

2 Residents

BWH

20 hours/year

2006-2007 Research Supervisor

1 Medical Student (Visiting Sarnoff Fellow) Mt. Sinai

School of Medicine

While Visiting at BWH

50 hours/year

2008-2011 Research Supervisor

1 Ph.D. Candidate GSAS Decision Science Concentrator

HSPH

26 hours/year

2009-2012 Research Supervisor, Harvard Initiative for Global

Health Summer Undergraduate Research Fellowship

Program

Harvard College

4 hours/week for 7

weeks

Formally Mentored Harvard Medical, Dental and Graduate Students

2008-2009 Adrianna Murphy, HSPH Class of 2009, MPH

“Cost effective analysis of community health workers in hypertension management.”

2008-2012 Ankur Pandya, HSPH Class of 2012, PhD

Topic: Optimization of cardiovascular disease screening and projection efforts in the

US.

“A comparative assessment of non-laboratory-based versus commonly used laboratory-

based cardiovascular disease risk scores in the NHANES III population.” Published in

PLoS One, 2011;6(5):e20416.

“Comparing Fifteen Approaches of Assessing Cardiovascular Disease Risk Using

Receiver Operating Characteristic (ROC) Curve Analysis.” presented at The 34th

Annual Meeting of the Society for Medical Decision Making; 2012: SMDM.

“Comparative assessment of absolute cardiovascular disease risk characterization from

non-laboratory-based risk assessment in South African populations.” BMC Medicine.

2013;11(1):170.

2009-2010 Grace Kim, Undergraduate, HC.

Presented undergraduate thesis, “Cost of treating non-optimal blood pressure in low and

middle income countries compared to the US.”

2010-2011 Neil Patel, Undergraduate, HC.

Presented undergraduate thesis, “The potential reduction in cardiovascular mortality

through a nurse led hypertension treatment program.”

Other Mentored Trainees and Faculty:

2005-2006 Asaf Bitton, MD / Assistant Professor of Medicine, BWH

14

Career Stage: General Internal Medicine Fellow, BWH. Mentoring role: research

supervisor. Accomplishments: produced economic evaluation of tobacco control

strategies in South Africa.

2006-2009 Gene Kwan, MD, MPH / Instructor, Boston University School of Medicine

Career Stage: Resident, BWH. Mentoring role: research supervisor. Accomplishments:

produced salt reduction strategies evaluation.

2006-2009 Shuchi Anand, MD / Instructor, Stanford Medicine

Career Stage: Resident, BWH. Mentoring role: research supervisor. Accomplishments:

produced end stage renal disease and hypertension economic analysis.

2007-2008 Joshua Shulman-Marcus, MD / Assistant Professor of Medicine, Albany Medical Center

Career Stage: Sarnoff Fellow, Mt. Sinai School Of Medicine. Mentoring role: research

supervisor. Accomplishments: produced cost effective analysis of ECG analysis in

India.

2008-2009 Kerrune Ketlogetswe, MD / Cardiologist, MedStar Harbor Hospital

Career Stage: Resident, BWH. Mentoring role: research supervisor. Accomplishments:

produced economic evaluation of trans-fat reduction.

2010-2013 James Irlam, MBChB / Senior Lecturer, Primary Health Care Directorate, University of

Cape Town

Career Stage: Doctoral Student. Mentoring role: research supervisor. Accomplishments:

produced cost effective analyses of rheumatic heart disease management in South

Africa.

2010-2011 Neha Pagidipati, MD / Cardiologist, Duke University School of Medicine

Career Stage: Global Women’s Health Fellow, BWH. Mentoring role: research

supervisor. Accomplishments: produced CVD epidemiology in India.

2012-2016 Shafika Abrahams-Gessel, DrPH / Research Program Manager

Career Stage: Doctoral student. Mentoring role: dissertation committee member.

Accomplishments: first author on three publications and co-author on two more

publications as a result of dissertation work evaluating the effectiveness of community

health workers in screening for CVD in Bangladesh, Guatemala, Mexico and South

Africa.

2014-2015 Dugani, Chandrasagar, MD, PhD / Fellow, Saint Michael’s Hospital, Toronto, CA

Career Stage: Fellow, Dana Farber Cancer Institute. Mentoring role: research

supervisor. Accomplishments: published “25 by 25: Achieving Global Reduction in

Cardiovascular Mortality.” and “Variation in the Global Burden of Cardiovascular

Disease” in DCP3.

15

2016-2018 Thiago Jardim, MD, PhD / Cardiology Professor, Universidade Federal de Goiás,

Goiânia, Brazil

Career Stage: Lemann Foundation Cardiovascular Research Fellow. Mentoring role:

research supervisor. Accomplishments: published “Hypertension management in a

population of older adults in rural South Africa” in Journal of Hypertension and has

written three additional manuscripts on cardiovascular epidemiology that will be

published.

2016 - present Matthew Lawlor, MD / Resident, Brigham & Women’s Hospital

Career Stage: Intern, BWH. Mentoring role: research supervisor. Accomplishments: first

author on chapter in Braunwald Heart Disease and contributor to both UnitedHealthcare

Polypill and The Prevention and Wellness Trust Fund evaluations.

2017 Raul Martin Chapparro, MD / Research Fellow, Institute for Clinical Effectiveness

(IECS), Buenos Aires, Argentina.

Career Stage: D-43 Trainee. Mentoring role: research supervisor. Accomplishments:

completed HSPH course: Decision Analysis Methods in Public Health and Medicine,

and preparing Argentinian inputs for cost-effectiveness analysis.

Formal Teaching of Peers

Those presentations below sponsored by outside entities are so noted and the sponsor is identified.

2009 The Cardiovascular Polypill: Simple Solution or

Oversimplification?

BWH CV Review Course

One hour lecture

BWH

2011 Adult Clinical Cardiology Self-Assessment Program

(ACCSAP) 8, Chapter 1: General Principles and

Cardiovascular Medicine, Module 1.1: Global Burden

of CV Disease.

Online Training Module Section

2015

ACCSAP 9, Chapter 2: General Principles and

Cardiovascular Medicine, Module 2.1: Global Burden

of Cardiovascular Disease

Online Training Module Section

Local Invited Presentations

No presentations below were sponsored by outside entities.

2002, 2005 Cost-effectiveness analysis of hypertension guidelines in South Africa / Grand Rounds

Division of Cardiovascular Medicine, BWH, Boston, MA.

2009 Global Trends in Risk Assessment: Cardiovascular Disease in Developing Countries –

Moving Forward / Invited Lecture

Harvard Initiative for Global Health, Cambridge, MA.

16

2009 Diabetes and risk factor screening for cardiovascular disease: Toward a Global

Perspective on the Economics of Treating and Preventing Diabetes / Invited Lecture

Harvard Initiative for Global Health, Cambridge, MA.

2009 Analytic Tools - Disease models, costing tools, surveillance systems and other data

sources: Toward a Global Perspective on the Economics of Treating and Preventing

Diabetes / Panel Chair

Harvard Initiative for Global Health, Cambridge, MA.

2009 Development of Chronic Disease Program in Pakistan: United States-Pakistan Foreign

Relations Conference / Invited Lecture

Harvard International Relations Council, Boston, MA.

2011 Preparing for the UN General Assembly Meeting in September, 2011: What we do and

don't know about managing the growing chronic disease epidemic in developing

countries / Invited Seminar

Harvard Center for Population and Development Studies, Cambridge, MA.

2011 Prevention for emerging NCDs. The Long Tail of Global Health Equity:

Tackling the Endemic Non-Communicable Diseases of the Bottom Billion / Invited

Panelist

Harvard Medical School, Department of Global Health and Social Medicine, Boston,

MA.

2011 Treatment of Cardiovascular Disease in Developing Countries / Invited Lecture.

Massachusetts General Hospital (MGH), Boston, MA.

2012 Global Cardiovascular Disease: Challenges & Solutions. Research Seminar in Decision

Science / Invited Lecture

HPM, HSPH, Boston, MA.

2015 Cost-Effectiveness in Heart Failure / Invited Lecture

BWH Cardiovascular Division, Harvard Club of Boston, Boston, MA.

2017 Global CVD Challenges and Opportunities / Invited Lecture

Brigham and Women’s Faulkner Hospital, Boston, MA.

Report of Regional, National and International Invited Teaching and

Presentations

Invited Presentations and Courses

Those presentations below sponsored by outside entities are so noted and the sponsor(s) is (are) identified.

Regional

2005 Cardiovascular Disease Management in Developing Countries / Grand Rounds

Lemuel Shattuck Hospital. Jamaica Plain, MA

2007 Can we stem the tide of CVD in developing countries? / Grand Rounds

V.A. Medical Center, West Roxbury, MA.

17

2009 Global Burden of Cardiovascular Disease / Invited Lecture

Meeting of the Minds Cardiology Symposium, Montauk, NY.

2011 The Changing Landscape in Global Cardiovascular Disease: Challenges and Solution /

Grand Rounds / Invited Lecture

Tufts Medical Center, Boston, MA.

2013 Burden and Cost-Effective Management of Cardiovascular Disease in Low- and Middle-

Income Countries / Cardiology Grand Rounds / Invited Lecture

V.A. Boston Healthcare System, Boston, MA.

2016 Statins and the “New” Cholesterol Guidelines (LMIC) / Grand Rounds / Invited Lecture

Boston University Medical Center, Boston, MA.

National

2006 The Burden of Cardiovascular Disease: What’s at Stake? Conference on Cardiovascular

Disease and Its Impact on Society, Duke Health Sector Conference / Chair, Discussion

Panel

Duke University Medical Center, Durham, NC.

2006 Can we halve vascular mortality in India in 10 years? Cost-effectiveness of a generic risk

pill. / Invited Lecture

Fogarty International Center, NIH, Bethesda, MD.

2006 The Future State of Cardiovascular Disease: Today’s Decisions…Tomorrow’s Outcomes

/ Panel Discussion / Participant

National Heart Lung and Blood Institute, NIH, Bethesda, MD.

2007 Evaluating Prevention of CVD in Low and Middle-Income Countries; Conference on

Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke / Invited

Lecture

American Heart Association, Washington, D.C.

2007 Translating Knowledge to Tackle Cardiovascular Disease Globally: Symposium for NIH

Institute Directors on the future of research in developing countries / Invited Lecture

Fogarty International Center - Disease Control Priorities Project, Bethesda, MD.

2007 Cardiology Grand Rounds / Invited Lecture

Duke University, Durham, NC.

2007 Duke Clinical Research Institute Research Conference / Invited Lecture

Duke University, Durham, NC.

2008 Update of South Africa Center: Ovations Centre of Excellence / Invited Lecture

NHLBI/Ovations, Minneapolis, MN.

2008 Integrated Guidelines in developing countries: Ovations Center of Excellence / Invited

Lecture

NHLBI/Ovations, Minneapolis, MN.

18

2009 Committee on Preventing the Global Epidemic of Cardiovascular Disease / Invited

Lecture

Institute of Medicine of the National Academies, Washington D.C.

2009 Second Annual Fogarty Consultation with Global Health Leaders / Panel Discussant

Fogarty International Center, NIH, Bethesda, MD.

2009 Chronic Diseases in Emerging Countries / Panel Discussant

US Congressional Caucus, Washington D.C.

2010 Cost-effectiveness of CVD Prevention in Low- and Middle-Income Countries / Invited

Lecture

AHA Scientific Sessions 2010, Chicago, IL.

2011 Economic Modeling of CVD Risk Factor/Disease Interventions / Invited Lecture

Institute of Medicine Workshop, Washington D.C.

2011 Globalization/Urbanization and the Epidemiologic Transition: AHA Scientific Sessions /

Panel co-chair

AHA Scientific Sessions Meeting, Orlando, FL.

2012 Economic impact of CVD and cost-effective solutions: Plenary session / Invited Lecture

AHA Scientific Sessions. Los Angeles, CA.

2013 Global Cardiovascular Disease Careers. Outside the Box Session for Fellows in Training

/ Invited Lecture

ACC Scientific Sessions. San Francisco, CA.

2014 Evaluating the cost-effectiveness of the polypill? / Invited Lecture

11th Cardiovascular Clinical Trialists Forum. Washington, D.C.

2015 Increasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce

Savings In South Africa (Session: Prescription Drugs and NCDs) / Invited Lecture

Health Affairs Briefing, Washington, D.C. (Health Affairs)

2015 Cardiovascular Disease Screening By Community Health Workers Can Be Cost-Saving

And Cost-Effective In Low-Resource Countries (Session: Community Interventions and

NCDs) / Invited Lecture

Health Affairs Briefing, Washington, D.C. (Health Affairs)

2015 Decreasing the Global Burden of Cardiovascular Disease: Moving the Needle. Plenary

Session (Decreasing the Global Burden of Disease: Breakthroughs in Prevention) /

Invited Lecture

AHA Scientific Sessions 2015. Orlando, FL.

2016 A Cost-Effectiveness Analysis in the US of LCZ696 (Sacubitril/Valsartan) Versus

Renin-Angiotensin-Aldosterone System Inhibition for Heart Failure Patients

With Reduced Ejection Fraction (Session: Highlighted Original Research: Heart Failure,

Cardiomyopathies and the Year in Review) / Invited Lecture.

ACC 2016. Chicago, IL.

19

2017 A Global Perspective On Managing Diabetics With Coronary Artery Disease / Invited

Lecture

ACC Scientific Sessions, Washington, D.C.

2018 Challenges and Opportunities in Providing Global Cardiovascular Disease Care / Invited

Lecture

Duke University, Raleigh, NC

2018 Innovations in Global Cardiovascular Health: A Two Way Street / Invited Lecture

Duke University, Raleigh, NC

2018 mHealth Interventions to Improve Access and Coverage of Uninsured People with High

Cardiovascular Risk in Argentina: Results of a Cluster Randomized Pragmatic Trial /

Invited Lecture

2018 mHealth PI Network Meeting, Fogarty International Center, NIH, Bethesda, MD

International

2000 Medicine Grand Rounds: Groote Schuur Hospital / Invited Lecture

UCT Medical School, Cape Town, South Africa.

2003 Cost-Effective Management of Cardiovascular Disease in Developing Countries /

Invited Lecture

Gates Foundation, WHO, NIH, University of Toronto, Canada. (Gates Foundation)

2003 Improving Population Health: Implementation Of CVD Success Stories From

Developing Countries / Invited Lecture

Instituto Nacional De Salud Publica, Cuernavaca, Mexico. (Gates Foundation)

2005 What are the determinants of cost-effective cardiovascular disease care in developing

countries? / Plenary Presentation

WHF, International Conference on Preventive Cardiology, Iguaçu Falls, Brazil.

2005 Health Economics of Acute Coronary Syndrome Care: Can the Developing Countries

Afford It? / Invited Lecture

Initiative for Cardiovascular Health Research in the Developing Countries, Delhi, India.

2005 The Economic Impact of Primary Prevention / Invited Lecture

2nd Partners International Cardiovascular Conference, Dubai, United Arab Emirates.

2005 The Evolution of Guidelines for Cardiovascular Disease /Invited Lecture

2nd Partners International Cardiovascular Conference, Dubai, United Arab Emirates.

2006 Cardiovascular Disease: Disease Control Priorities Project (DCPP) Launch / Plenary

Presentation

WHO, World Bank, NIH, Gates Foundation, Inter-Academy Medical Panel, Beijing,

China.

2007 Cost-effective Management of Hypertension in Africa / Invited Lecture

Pan African Society of Cardiology, Nairobi, Kenya.

20

2007 The Economic Importance of Hypertension – Guideline Development / Invited Lecture

Asian Pacific Society of Hypertension, Beijing, China.

2007 Cost of hypertension in the Asian Pacific Region / Invited Lecture

9th International Symposium on Hypertension and Related Diseases, Asian Pacific

Congress of Hypertension, Beijing, China.

2007 Scaling up interventions for chronic disease prevention: the evidence / Invited Lecture

The Lancet Series on Chronic Diseases, Lancet United Kingdom Department of Health,

London, United Kingdom.

2009 Research and Action on Global Cardiovascular Disease in the Commonwealth

Countries / Invited Lecture

University of Toronto, Toronto, Canada.

2009 The Business Case for Cardiovascular Interventions / Invited Lecture

Macroeconomics of Cardiovascular Disease in Developing Countries Meeting, Delhi,

India.

2009 An Update on Risk Calculation: Did Framingham Reach the Limits? / Invited Lecture

Cardiology at the Limits; UCT, Cape Town, South Africa.

2009 South Africa Center of Excellence Inauguration / Chair

NHBLI, Cape Town, South Africa.

2009 Simplified CVD Risk Screening: Beyond Framingham / Invited Lecture

South Africa Center of Excellence Inauguration, NHBLI, Cape Town, South Africa.

2009 Cost-effectiveness of Interventions, Global Cardiovascular Disease Policy: Working

Group Meeting / Invited Lecture

Centre for Global Health Research (CGHR), St. Michael’s Hospital, University of

Toronto, Toronto, Canada.

2009 Prevention and treatment of chronic disease in developing countries / Invited Lecture

Expert Group Meeting on Health Mortality and Development, United Nations, New

York, NY.

2010 Reducing the Chronic Disease Burden with Limited Resources: DCP2 and Other

Experiences / Invited Lecture

Disease Control Priorities Network: South Africa, Cape Town, South Africa.

2010 The polypill is a cost-effective approach to prevention of cardiovascular diseases in

low- and middle income countries / Invited Lecture

World Congress of Cardiology, WHF, Beijing, China.

2010 Non-laboratory based risk assessment of chronic disease in low and middle income

countries / Invited Lecture

World Congress of Cardiology, WHF, Beijing, China.

2010 Cost effectiveness of hypertension guidelines in South Africa / Invited Lecture

World Congress of Cardiology, WHF, Beijing, China.

2010 Economic consequences of untreated CVD in developing countries / Invited Lecture

21

World Congress of Cardiology, WHF, Beijing, China.

2011 A Global Perspective on CVD, Diabetes, and Obesity / Keynote Lecture

DALM XVII International Symposium on Diabetes, Obesity & the Metabolic

Syndrome, Doha, Qatar. (Drugs Affecting Lipid Metabolism)

2011 Economic studies on hypertension in developing countries – a preliminary analysis /

Invited Lecture

NHLBI Global Health Initiative: Preventing Chronic Disease and UNITEDHEALTH’s

4th Semi-Annual Steering Committee Meeting, Antigua, Guatemala.

2012 Using Community Health Workers to Manage Hypertension in Urban India: A Cost

effectiveness Analysis / Invited oral presentation of accepted poster (delivered by co-

author of poster, A. Murphy)

Irish Forum for Global Health International Conference, Dublin, Ireland.

2012 Cost effectiveness of combination polypharmacy / Invited Lecture

The Global Summit on Combination Polypharmacy For Cardiovascular Disease.

Hamilton, Ontario, Canada.

2012 Impact of reduced salt and increased screening on CVD burden and health costs /

Invited Lecture

World Congress of Cardiology, 2012, Dubai, United Arab Emirates.

2012 The polypill is a cost-effective approach to primary prevention of cardiovascular

diseases / Invited Debate

World Congress of Cardiology 2012, Dubai, United Arab Emirates.

2013 Diabetes, HbA1c, insulin, and mortality—The search for the Holy Grail / Invited

Lecture

UCT Medical School, Cape Town, South Africa.

2013 Cost-effectiveness analysis of heart failure management / Invited Lecture

UCT Medical School, Cape Town, South Africa.

2014 CVD Prevention: what is behind the screen? / Recipient of Fred Epstein Memorial

Lecture Award – Invited Lecture

The European Association for Cardiovascular Prevention and Rehabilitation’s

EuroPRevent, 2014, Amsterdam, Netherlands. (European Society of Cardiology)

2014 What is the population at CVD risk: Using the US risk calculator / Invited Lecture

The European Association for Cardiovascular Prevention and Rehabilitation’s

EuroPRevent, 2014, Amsterdam, Netherlands. (European Society of Cardiology)

2014 Clinical Effectiveness Course: Implementing Policies in cardiovascular prevention /

Invited Teaching Faculty

Institute of Clinical and Health Effectiveness, Southern Cone American Center Of

Excellence Of Cardiovascular Health, 2014, Buenos Aires, Argentina (NIH supported

D-43 grant).

2016 On the Front Line: The Role of Front Line Health Workers in Preventing and Treating

22

Cardiovascular Disease and NCDs (Session: NCD Café. From Prevention to Care: A

Comprehensive Response. ) / Invited Lecture

World Congress of Cardiology and Cardiovascular Health, Mexico City, Mexico.

2016 Cost-effectiveness interventions for cardiovascular and respiratory diseases. (Session:

Disease Control Priorities (DCP)3: Volume on Cardiovascular, Respiratory, and

Related Disorders) / Invited Lecture

World Congress of Cardiology and Cardiovascular Health, Mexico City, Mexico.

2017 Access to essential and affordable medicines and technologies. (Knowledge Exchange

Workshop) / Invited Lecture

Second World Heart Federation Global Summit on Circulatory Health, Singapore

2017 The Role of Task Sharing to Implement Cardiovascular Disease Prevention. / Invited

Lecture

Asian Pacific Society of Cardiology Congress, Singapore

2017 The Global Hearts Initiative – using technical packages to drive action. (Workshop:

Promoting Best Buys for NCDs: Making the Case) / Invited Lecture

Global NCD Alliance, Sharjah, UAE.

Report of Clinical Activities and Innovations

Current Licensure and Certification

1996-present Massachusetts Board of Registration in Medicine

1999-2009 American Board of Internal Medicine, Diplomate in Internal Medicine

2003, 2013 American Board of Internal Medicine, Diplomate in Cardiovascular Diseases

Practice Activities

2003-present Inpatient Cardiology, B Team

Division of Cardiology,

BWH

1 month/year

2016-present Inpatient Cardiology

Consultative Services,

Dept. of Medicine,

Spaulding Hospital

Cambridge

3 months/year

Report of Education of Patients and Service to the Community

No presentations below were sponsored by outside entities.

Education of Patients and Service to the Community

2007 Community Senior Center/Clinician

Participated in blood pressure screening and gave presentation about lifestyle

changes to improve cardiac risks

23

Report of Scholarship

Peer-Reviewed Scholarship in print or other media

Research Investigations

1. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens

CH, Buring JE. Light-to-moderate alcohol consumption and mortality in the Physicians' Health

Study enrollment cohort. J Am Coll Cardiol. 2000;35(1):96-105.

2. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J, Hypertension in South African adults:

results from the Demographic and Health Survey, 1998. J Hypertens. 2001;19(10):1717-25.

3. Zimetbaum P, Reynolds MR, Ho KK, Gaziano T, McDonald MJ, McClennen S, Berezin R,

Josephson ME, Cohen DJ. Impact of a practice guideline for patients with atrial fibrillation on

medical resource utilization and costs. Am J Cardiol. 2003;92(6):677-81.

4. Steyn K, Levitt NS, Hoffman M, Marais AD, Fourie JM, Lambert EV, Gaziano TA, Kepe L,

Lombard CJ. The global cardiovascular diseases risk pattern in a peri-urban working-class

community in South Africa. The Mamre study. Ethn Dis. 2004;14(2):233-42.

5. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of

hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation.

2005;112(23):3569-76.

6. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management.

Circulation. 2005;112(23):3547-53.

7. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug

regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006;368(9536):679-86.

8. Norman R, Gaziano T, Laubscher R, Steyn K, Bradshaw D, and the South African Comparative

Risk Assessment Collaborating Group. Estimating the burden of disease attributable to high blood

pressure in South Africa in 2000. S Afr Med J. 2007;97(8):692-698.

9. Norman R, Bradshaw D, Steyn K, Gaziano TA, and the South African Comparative Risk

Assessment Collaborating Group. Estimating the burden of disease attributable to high cholesterol

in South Africa in 2000. S Afr Med J. 2007;97(8):708-715.

10. Lim S, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Prevention of

cardiovascular disease in high-risk individuals in low-income and middle-income countries: health

effects and costs. Lancet. 2007 Dec 15;370(9604):2054-62. Epub 2007 Dec 11.

11. Gaziano TA, Young C, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-

laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up

study cohort. Lancet. 2008 Mar 15; 371(9616): 923-31.

12. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in

bare-metal versus drug-eluting stents results of a decision analytic model. Journal of the American

College of Cardiology.13 May 2008;51(19):1844-1853.

13. Gaziano TA, Bitton A, Anand S, Weinstein MC on behalf of the International Society of

Hypertension. The global cost of nonoptimal blood pressure. J of Hypertension. 2009 July;

27(7):1472-1477.

14. Lambert EV, da Silva R, Fatti L, Patel D, Kolbe-Alexander T, Derman W, Noach A, Nossel C,

Gaziano T. Fitness-related activities and medical claims related to hospital admissions – South

Africa, 2006. Prev Chronic Dis. 2009 Oct;6(4):A120.

15. Patel DN, Lambert EV, da Silva R, Greyling M, Nossel C, Noach A, Derman W, Gaziano TA.

The association between medical costs and participation in the Vitality Health Promotion Program

among 948,974 members of a South African health insurance company. American Journal of

Health Promotion, Jan/Feb 2010; V24(I3):199-204.

24

16. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary

heart disease in low- and middle-income countries. Current Problems in Cardiology, February

2010; 35(2):72-115.

17. Schulman-Marcus J, Prabhakaran D, Gaziano TA. Pre-hospital ECG for acute coronary syndrome

in urban India: A cost-effectiveness analysis. BMC Cardiovascular Disorders. 2010 10(1): 13.

Highly Accessed.

18. Glassman A, Gaziano TA, Bouillon Buendia CP, Guanais de Aguiar FC. Confronting the chronic

disease burden in Latin America and the Caribbean. Health Affairs (Millwood). 2010 Dec;

29(12):2142-8.

19. Pandya A, Weinstein MC, Gaziano TA. A Comparative assessment of non-laboratory-based

versus commonly used laboratory-based cardiovascular disease scores in the NHANES III

population. PLoS One. 2011;6(5):e20416.

20. Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay VS, Goenka

S, Calcagno JI, Caporale JE, Niu S, Li Y, Liu J, Thankappan KR, Daivadanam M, van Esch J,

Murphy A, Moran AE, Gaziano TA, Suhrcke M, Reddy KS, Leeder S, Prabhakaran D. A cross-

sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low-

and middle-income countries. PLoS One. 2011;6(6):e20821.

21. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo

N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G,

Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M,

Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P,

Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J.

Priority actions for the non-communicable disease crisis. Lancet. 2011 Apr 23; 377(9775):1438-

47.

22. Patel D, Lambert EV, da Silva R, Greyling M, Kolbe-Alexander T, Noach A, Conradie J, Nossel

C, Borresen J, Gaziano T. Participation in fitness-related activities of an incentive-based health

promotion program and hospital costs: a retrospective longitudinal study. Am J Health Promot.

2011 May-Jun; 25(5):341-8.

23. Gaziano TA. Accurate hypertension diagnosis is key in efficient control. Lancet. 2011 Oct 1;

378(9798):1199-200.

24. Gaziano TA. Are we there yet?: Steps along the way toward implementing evidence-based heart

failure guidelines in middle-income countries. Circ Heart Fail. 2011 Nov 1; 4(6):682-4.

25. Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease

and use of therapy. PLoS One. 2013 Aug 30;8(8):e72860.

Among the top 10% most cited PLOS ONE articles.

26. Gaziano TA, Pagidipati N. Scaling up chronic disease prevention interventions in lower- and

middle-Income countries. Annu.Rev.Public Health. 2013 March 1; 34: 9.1-9.18.

27. Pagidipati NJ, Gaziano TA. Estimating deaths from cardiovascular disease: A review of global

methodologies of mortality measurement. Circulation. 2013 Feb 12; 127: 749-756.

28. Irlam JH, Mayosi BM, Engel ME, Gaziano TA. Primary prevention of acute rheumatic fever and

rheumatic heart disease with penicillin in South African children with pharyngitis: A cost-effective

analysis. Circulation: Cardiovascular Quality and Outcomes. 2013 May 7; 6: 343-351.

29. Casey JD, Vaidya A, Solomon DH, Gaziano TA. Interactive medical case: A patient with

migrating polyarthralgias. N Engl J Med. 2013 Jun 13;368(24):e33.

30. Gaziano TA, Pandya A, Steyn K, Levitt N, Mollentze W, Joubert G, Walsh CM, Motala AA,

Kruger A, Schutte AE, Naidoo DP, Prakaschandra DR, Laubscher R. Comparative assessment of

absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in

South African populations. BMC Med 2013 Jul 24;11:170

25

31. Irlam JH, Mayosi BM, Engel ME, Gaziano TA. A cost-effective strategy for primary prevention

of acute rheumatic fever and rheumatic heart disease in children with pharyngitis. South African

Medical Journal. 2013 May 1; 103(12): 894-5.

32. Pandya A, Gaziano TA, Weinstein MC, Cutler D. More Americans living longer with

cardiovascular disease will increase costs while lowering quality of life. Health Affairs. 2013 Oct;

32 (10): 1706-1714.

33. Valluri S, Gaziano TA. Progress in national and regional guidelines development and deployment

for the clinical prevention and control of CVD and diabetes in Africa. Prog Cardiovasc Dis. 2013

Sept 28; 56(3): 336-343.

34. Pandya A, Weinstein MC, Salomon JA, Cutler D, Gaziano TA. Who needs laboratories and who

needs statins?: Comparative and cost-effectiveness analysis of non-laboratory-based, laboratory-

based, and staged primary cardiovascular disease screening guidelines. Circ Cardiovasc Qual

Outcomes. 2014 Jan 14; 7(1): 25-32.

35. Irlam JH, Mayosi BM, Engel ME, Gaziano TA, Whitelaw AC. Irlam et al. respond. S Afr Med J.

2014 Mar;104(3):157. PubMed PMID: 24897810.

36. Gaziano TA, Bertram M, Tollman SM, Hofman KJ. Hypertension education and adherence in

South Africa: A cost-effectiveness analysis of community health workers. BMC Public Health.

2014 Mar 10; 14(240).

37. Peer N, Lombard C, Steyn K, Gaziano T, Levitt N: Comparability of total cardiovascular disease

risk estimates using laboratory and non-laboratory based assessments in urban-dwelling South

Africans: The CRIBSA study. South African Medical Journal. 2014, 104(10):691-696.

38. Surka S, Edirippulige S, Steyn K, Gaziano T, Puoane T, Levitt N. Evaluating the use of mobile

phone technology to enhance cardiovascular disease screening by community health workers. Int J

Med Inform. 2014 Sep;83(9):648-54.

39. Peer N, Steyn K, Lombard C, Gaziano T, Levitt N. Alarming rise in prevalence of atherogenic

dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South

Africans (CRIBSA) study. Eur J Prev Cardiol. 2014 Dec;21(12):1549-56.

40. Abrahams-Gessel S, Denman CA, Montano CM, Gaziano TA, Levitt N, Rivera-Andrade A,

Carrasco DM, Zulu J, Khanam MA, Puoane T. The Training and Fieldwork Experiences of

Community Health Workers Conducting Population-Based, Noninvasive Screening for CVD in

LMIC. Glob Heart 2015;10:45-54.

41. Abrahams-Gessel S, Denman CA, Montano CM, Gaziano TA, Levitt N, Rivera-Andrade A,

Carrasco DM, Zulu J, Khanam MA, Puoane T. Training and Supervision of Community Health

Workers Conducting Population-Based, Noninvasive Screening for CVD in LMIC: Implications

for Scaling Up. Glob Heart 2015;10:39-44.

42. Gaziano TA., Abrahams-Gessel Shafika, Denman Catalina A., Mendoza Montano Carlos,

Khanam Masuma, Puoane Thandi, Levitt Naomi S. An assessment of community health workers'

ability to screen for cardiovascular disease risk with a simple, non-invasive risk assessment

instrument in Bangladesh, Guatemala, Mexico, and South Africa: an observational study. The

Lancet Global Health. 2015;3(9):e556-563.PMID: PMC4795807

43. Levitt, Naomi S., Puoane, Thandi, Denman, Catalina A., Abrahams-Gessel, Shafika, Surka, Sam,

Mendoza, Carlos, Khanam, Masuma, Alam, Sartaj, Gaziano, Thomas A. Referral outcomes of

individuals identified at high risk of cardiovascular disease by community health workers in

Bangladesh, Guatemala, Mexico, and South Africa. Glob Health Action 2015; 8

44. N Folb, V Timmerman, N S Levitt, K Steyn, M O Bachmann, C Lund, E D Bateman, C Lombard,

T A Gaziano, M Zwarenstein, L R Fairall. Multimorbidity, control and treatment of non-

communicable diseases among primary healthcare attenders in the Western Cape, South Africa.

SAMJ: South African Medical Journal. 2015;105(8):642-7.

26

45. Pandya, A; Sy, S; Cho, S; Weinstein, MC, Gaziano, Thomas A. Cost-effectiveness of 10-Year

Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

JAMA. 2015;314(2):142-150.

46. Thomas Gaziano, Sylvia Cho, Stephen Sy, Ankur Pandya, Naomi S. Levitt, Krisela Steyn.

Increasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce Savings In

South Africa. Health Affairs. September 2015 34: 1578-1585.

47. Thomas Gaziano, Shafika Abrahams-Gessel, Sam Surka, Stephen Sy, Ankur Pandya, Catalina

A. Denman, Carlos Mendoza, Thandi Puoane, Naomi S. Levitt. Cardiovascular Disease Screening

By Community Health Workers Can Be Cost-Effective In Low-Resource Countries. Health

Affairs. September 2015 34:1538-1545.

48. Mash R, Kroukamp R, Gaziano T, Levitt N. Cost-effectiveness of a diabetes group education

program delivered by health promoters with a guiding style in underserved communities in Cape

Town, South Africa. Patient education and counseling. 2015;98(5):622-6.

49. Jaacks LM, Ali MK, Bartlett J, Bloomfield GS, Checkley W, Gaziano TA, Heimburger DC,

Kishore SP, Kohler RE, Lipska KJ, Manders O, Ngaruiya C, Peck R, Burroughs Peña M, Watkins

DA, Siegel KR, Narayan KMV . Global Noncommunicable Disease Research: Opportunities and

Challenges. Annals of internal medicine 163.9 (2015): 712-714.

50. Lubitz CC, Economopoulos KP, Sy S, Johanson, C. Kunzel, HE, Reincke, M, Gazelle, GS,

Weinstein, MC, Gaziano, TA. Cost-Effectiveness of Screening for Primary Aldosteronism and

Subtype Diagnosis in the Resistant Hypertensive Patients. Circulation: Cardiovascular Quality

and Outcomes. 2015;8(6):621-630.

51. Surka S, Steyn K, Everett-Murphy K, Gaziano TA, Levitt N. Knowledge and perceptions of risk

for cardiovascular disease: findings of a qualitative investigation from a low-income peri-urban

community in the Western Cape, South Africa. African Primary Health Care and Family Medicine.

2015;7(1):1-8.

52. Dugani S, Gaziano TA. 25 by 25: Achieving Global Reduction in Cardiovascular Mortality. Curr

Cardiol Rep. 2016;18(1):10.

53. Gaziano TA, Abrahams-Gessel S, Alam S, Alam D, M. Ali, Bloomfield G, Carrillo-Larco RM,

Dorairaj P, Gutierrez L, Irazola V, Levitt NS, Miranda JJ, Bernabe-Ortiz A, Pandya A, Rubinstein

A, Steyn K, Xavier D and Y. LL (2016). Comparison of Nonblood-Based and Blood-Based Total

CV Risk Scores in Global Populations. Global Heart 11 (1)(March): 37-46.

54. Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, et al.

Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities:

Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases. Global

Heart. 2016;11(1):47-59.

55. Carrillo-Larco RM, Miranda JJ, Li X, Cui C, Xu X, Ali M, Alam DS, Gaziano TA et al.

Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From

10 LMIC Areas in Africa, Asia, and South America. Global Heart. 2016;11(1):27-36.

56. Abrahams-Gessel S, Denman CA, Gaziano TA, Levitt NS, Puoane T. Challenges Facing

Successful Scaling Up of Effective Screening for Cardiovascular Disease by Community Health

Workers in Mexico and South Africa: Policy Implications. Health Syst Policy Res. 2016;3(1).

PMC4855872

57. Patel SA, Ali MK, Alamy D, Yanz LL, Levittk NS, Bernabe-Ortiz A, Checkley W, Wuz Y,

Irazola V, Gutierrez L, Rubinstein A, Shivashankar R, Liz X, Miranda JJ, Chowdhury MAH,

Siddiquee AT, Gaziano TA, Kadir MM and Prabhakaran D. Obesity and its Relation With

Diabetes and Hypertension: A Cross-Sectional Study Across 4 Geographical Regions. Global

Heart. 2016;11:77-79.

27

58. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, Heidenreich PA, Huffman

MD, Mayosi BM, Mendis S, Murray CJL, Perel P, Piñeiro DJ, Smith SC Jr, Taubert KA, Wood

DA, Zhao D, Zoghbi WA. The heart of 25 by 25: achieving the goal of reducing global and

regional premature deaths from cardiovascular diseases and stroke: a modeling study from the

American Heart Association and World Heart Federation. Circulation. 2016;133:e674–e690. doi:

10.1161/CIR.0000000000000395.

59. Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, Rouleau

JL, Zile MR, McMurray JJV, Solomon SD. Cost-effectiveness Analysis of Sacubitril/Valsartan vs

Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiology.

2016;1(6):666-672. doi:10.1001/jamacardio.2016.1747.

60. Fairall LR, Folb N, Timmerman V, Lombard C, Steyn K, Bachmann MO, Bateman ED, Lund C,

Cornick R, Faris G, Gaziano T, Georgeu-Pepper D, Zwarenstein M and Levitt NS. Educational

Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease

Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial.

PLOS Medicine. 2016 Nov 22;13:e1002178.

61. Folb N, Bachmann MO, Bateman ED, Steyn K, Levitt NS, Timmerman V, Lombard C, Gaziano

TA, Fairall LR. Socioeconomic and modifiable predictors of blood pressure control for

hypertension in primary care attenders in the Western Cape, South Africa.S Afr Med J 2016 1241-

46.

62. Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, Handler J,

Krumholz HM, Kushner RF, MacKenzie TD, Sacco RL, Smith SC Jr, Stevens VJ, Wells BL,

Castillo G, Heil SK, Stephens J, Vann JC. ACC/AHA Special Report: Clinical Practice Guideline

Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation

Science Work Group: A Report of the American College of Cardiology/American Heart

Association Task Force on Clinical Practice Guidelines. Circulation, 2017 Feb 28;135(9):e122-

e137.

63. Chan WV, Pearson TA, Bennett GC, Cuyshman, WC, Gaziano TA, Gorman PN, Handler J,

Krumholz HM, Kushner RF, MacKenzie TD, Sacco RL, Smith SC Jr, Stevens VJ, Wells BL.

ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of

Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the

American College of Cardiology/American Heart Association Task Force on Clinical Practice

Guidelines. J Am Coll Cardiol. 2017;69(8):1076-1092.

64. Gaziano TA, Abrahams-Gessel S, Gomez-Olive FX, et al. Cardiometabolic risk in a population of

older adults with multiple co-morbidities in rural south africa: the HAALSI (Health and Aging in

Africa: longitudinal studies of INDEPTH communities) study. BMC Public Health.

2017;17(1):206.

65. Jardim TV, Reiger S, Abrahams-Gessel S, Gomez-Olive FX, Wagner RG, Wade A, Bärnighausen

TW, Salomon J, Tollman S, Gaziano TA. Hypertension management in a population of older

adults in rural South Africa. Journal of Hypertension. 2017;35:1283-1289. PMC5505070

66. Puoane T, Abrahams-Gessel S, Gaziano TA, Levitt N. Training of Community Health Workers

to screen for Cardiovascular Disease risk in the community: Experiences from Cape Town, South

Africa. Cardiovascular Journal of Africa. 2017; 28(3):170-175.

67. Pandya A, Sy S, Cho S, Alam S, Weinstein MC, Gaziano TA. Validation of a Cardiovascular

Disease Policy Micro-simulation Model Using Both Survival and Receiver Operating

Characteristic Curves. Medical Decision Making. 2017; Oct;37(7):802-814. doi:

10.1177/0272989X17706081. PMCID: PMC5577377

28

68. Jardim TV, Gaziano TA, Nascente FM, et al. Office blood pressure measurements with

oscillometric devices in adolescents: a comparison with home blood pressure. Blood Pressure.

2017:1-7.

69. Manne-Goehler J, Montana L, Gómez-Olivé FX, Rohr J, Harling G, Wagner R, Wade A,

Kabudula C, Geldsetzer P, Kahn K, Tollman S, Berkman L, Bärnighausen T, Gaziano TA. The

ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa. J

Acquir Immune Defic Syndr 2017;75:561-567. PMCID: PMC5516957

70. Reiger S, Jardim TV, Abrahams-Gessel S, Crowther NJ, Wade A, Gomez-Olive FX, Salomon J,

Tollman S, Gaziano TA. Awareness, treatment, and control of dyslipidemia in rural South Africa:

The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in

South Africa) study. PLoS One. 2017 Oct 27;12(10):e0187347. PMC5659770

71. Peñalvo JL, Cudhea F, Micha R, Rehm CD, Afshin A, Whitsel L, Wilde P, Gaziano T, Pearson-

Stuttard J, O’Flaherty M, Capewell S and Mozaffarian D. The potential impact of food taxes and

subsidies on cardiovascular disease and diabetes burden and disparities in the United States. BMC

Medicine. 2017 Nov 27;15(1):208.

72. Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya JC and Nugent R.

Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities,

3rd edition. Lancet. 2017 Nov 3. pii: S0140-6736(17)32471-6. doi: 10.1016/S0140-

6736(17)32471-6.

73. Jardim TV, Reiger S, Abrahams-Gessel S, Crowther NJ, Wade A, Gómez-Olivé FX, Salomon J,

Tollman S, Gaziano TA. Disparities in Management of Cardiovascular Disease in Rural South

Africa: Data From the HAALSI Study (Health and Aging in Africa: Longitudinal Studies of

International Network for the Demographic Evaluation of Populations and Their Health

Communities). Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). PMC5777525

74. Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, Anand S, Atun R, Bertozzi S,

Bhutta Z, Binagwaho A, Black R, Blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D,

Cieza A, Cullen M, Danforth K, de Silva N, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan

M, Garcia PJ, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D,

Holmes KK, Horton S, Hutton G, Jha P, Knaul FM, Kobusingye O, Krakauer EL, Kruk ME,

Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC,

Measham A, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z,

Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J,

Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M,

Tollman S, Verguet S, Walker DG, Walker N, Wu Y, Zhao K. Universal health coverage and

intersectoral action for health: key messages from Disease Control Priorities, 3rd edition. Lancet.

2017 Nov 24. pii: S0140-6736(17)32906-9. doi: 10.1016/S0140-6736(17)32906-9. [Epub ahead of

print]

75. Gómez-Olivé, F. Xavier, Montana, Livia, Wagner, Ryan G., Kabudula, Chodziwadziwa W., Rohr,

Julia K., Kahn, Kathleen, Bärnighausen, Till, Collinson, Mark, Canning, David, Gaziano,

Thomas, Salomon, Joshua A., Payne, Collin F., Wade, Alisha, Tollman, Stephen M., Berkman,

Lisa. Cohort Profile: Health and Ageing in Africa: a Longitudinal Study of an INDEPTH

Community in South Africa (HAALSI). International Journal of Epidemiology. 2018, 1-12. doi:

10.1093/ije/dyx247

76. Fairall L, Petersen I, Zani B, Folb N, Georgeu-Pepper D, Selohilwe O, Petrus R, Mntambo N,

Bhana A, Lombard C, Bachmann M, Lund C, Hanass-Hancock J, Chisholm D, McCrone P,

Carmona S, Gaziano T, Levitt N, Kathree T, Thornicroft G, CobALT research team. (2018).

Collaborative care for the detection and management of depression among adults receiving

29

antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.

Trials, 19(1), 193. doi:10.1186/s13063-018-2517-7

77. Petersen I, Bhana A, Folb N, Thornicroft G, Zani B, Selohilwe O, Petrus R, Mntambo N,

Georgeu-Pepper D, Kathree T, Lund C, Lombard C, Bachmann M, Gaziano T, Levitt N, Fairall

L, PRIME-SA research team. (2018). Collaborative care for the detection and management of

depression among adults with hypertension in South Africa: study protocol for the PRIME-SA

randomised controlled trial. Trials, 19(1), 192. doi:10.1186/s13063-018-2518-6

78. Abrahams-Gessel, S., Beratarrechea, A., Irazola, V., Gutierrez, L., Moyano, D., Fernandez, A.,

Ciganda, A., Celis, L.A., Winkler, E., Rubinsein, A., Gaziano, T. A. (2018). Using mHealth tools

to improve access, coverage and treatment of uninsured people with high cardiovascular disease

risk in Argentina: a study protocol for a pragmatic cluster randomised trial. BMJ Innovations. doi:

10.1136/bmjinnov-2017-000255

Other peer-reviewed scholarship

1. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world.

Health Aff (Millwood). 2007;26(1):13-24.

2. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the

evidence. Lancet. 2007 Dec 8;370(9603):1939-46.

3. Bitton A, Gaziano TA. The Framingham Heart Study’s Impact on Global Risk Assessment. Prog

Cardiovasc Dis, 2010 53(1) 68-78.

4. Casey JD, Solomon DH, Gaziano TA, Miller AL, Loscalzo J. Migrating polyarthralgias and a

migrating diagnosis. NEJM 2013 July 4;369(1):75-80.

5. Gaziano JM, Gaziano TA. What’s new with measuring cholesterol? JAMA. 2013 Nov 20;

310(19): 2043-4.

Non-peer reviewed scholarship in print or other media

Proceedings of meetings or other non-peer reviewed scholarship

1. Gaziano TA. Cardiovascular Disease in the Developing World and its Cost-Effective

Management. Cardiology Rounds. SNELL Medical Communication Inc.; 2005.

2. Gaziano TA, and G. I. Kim. Cost of treating non-optimal blood pressure in select low and middle

income countries in comparison to the United States. Boston, MA, 2009: Background Paper

Commissioned by the Committee on Preventing the Global Epidemic of Cardiovascular Disease,

Board on Global Health, Institute of Medicine. Promoting Cardiovascular Health in the

Developing World: A Critical Challenge to Achieve Global Health. Valentin Fuster and Bridget B.

Kelly, Editors.

3. Gaziano TA. Prevention and Treatment of Chronic Diseases in Developing Countries. Expert

Paper No. 2011/2. United Nations Department of Economic and Social Affairs: New York. 2011.

4. Country-Level Decision Making for Control of Chronic Diseases: Workshop Summary. 2012.

Washington (DC): The National Academies Press. [Invited Workshop Participant].

Reviews, chapters, monographs and editorials

1. Gaziano TA, Gaziano JM. Historical Perspective on Heart Disease and Worldwide Trends. Atlas

of Heart Disease Prevention. Gaziano JM, Braunwald, E, eds. Philadelphia: Current Medicine;

2005.

2. Rodgers A, Lawes CMM, Gaziano TA, Vos T. The growing burden of Risk from High Blood

Pressure, Cholesterol, and Bodyweight. In: Jamison, DT, Breman JG, Measham AR, Alleyne G,

30

Claeson M, Evans DB, Jha P, Mills A, Musgrove P editors. Disease Control Priorities in

Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 45.

3. Gaziano T, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular Disease. In: Jamison

DT, Bremand JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P,

editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World

Bank; 2006. Chapter 33.

4. Willet W, Koplan J, Nugent R, Puska P, Dusenbury C, Gaziano TA. Prevention of Chronic

Disease by Diet and Lifestyle Changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G,

Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in

Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 44.

5. Gaziano TA. The South African Hypertension Guideline 2006 is evidence-based but not cost-

effective. S Afr Med J. 2006;96(11):1170-3. 8.

6. Gaziano TA, Gaziano JM. Epidemiology of Cardiovascular Disease. Harrison's Principles of

Internal Medicine, Ed. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL,

Loscalzo J. New York: McGraw-Hill, 2008.

7. Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases

in Africa. Heart. 2008 Feb; 94(2): 140-4. Review.

8. Gaziano TA. Know Your Risk: But How? Indian J Med Res. 2008 Sep; 128:4-7. Editorial.

9. Gaziano TA. Is the horse already out of the barn in rural India? Circulation. 2009 April 14;

119(14):1850-1852. Editorial.

10. Gaziano JM, Gaziano TA,. Simplifying the Approach to the Management of Dyslipidemia.

JAMA. 2009;302(19):2148-2149.

11. Glassman A, Gaziano TA, Bouillon Buendia CP, Guanais de Aguiar FC. Confronting the chronic

disease burden in Latin America and the Caribbean. Health Aff (Millwood). 2010; 29(12):2142-8.

12. Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S.,

Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B.,

Stein, A., & Weinstein, C. (2011). The Global Economic Burden of Non-communicable Diseases.

Geneva: World Economic Forum.

13. Gaziano TA, Gaziano JM. Epidemiology of Cardiovascular Disease. Harrison's Principles of

Internal Medicine, 18th edition, Ed. Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo.

New York: McGraw-Hill, 2012.

14. Gaziano TA, Gaziano JM. Global Burden of Cardiovascular Disease. Braunwald’s Heart

Disease: A Textbook of Cardiovascular Medicine, 9th edition, Ed. Bonow R, Mann DL, Zipes DP,

Libby P. Philadelphia, PA: Elsevier Saunders, 2012.

15. Gaziano TA, Pagidipati N. Global Cardiovascular Therapy. Cardiovascular Therapeutics: A

Companion to Braunwald’s Heart Disease, 4th Edition, Ed. Antman EM and Sabatine MS.

Philadelphia, PA: W.B. Saunders Company, 2012.

16. Gaziano TA. The Devil Is in the Details: Achieving Reductions in Global Cardiovascular Disease

Mortality. Circulation: Cardiovascular Quality and Outcomes. 2015;8(6):535-538.

17. Gaziano TA, Gaziano JM. Global Evolving Epidemiology, Natural History, and Treatment

Trends of Myocardial Infarction. Myocardial Infarction: A Companion to Braunwald's Heart

Disease, Ed. Morrow DA. Philadelphia, PA: Elsevier Health Sciences, 2016.

18. Gaziano TA. Closing the Gap Between Clinical Trials and Practice: A Global Imperative. Journal

of the American College of Cardiology. 2016;67:2392-2394.

19. Gaziano TA. Lifestyle and Cardiovascular Disease: More Work to Do. Journal of the American

College of Cardiology. 2017;69(9):1126-1128.

Letters to the Editor

31

1. Irlam J, Mayosi BM, Gaziano TA. Rheumatic fever and rheumatic heart disease: primary

prevention is the cost effective option. Indian J Pediatr. 2008 Jan;75(1):86-7. Letter.

2. Gaziano TA, Opie LH. Body-mass index and mortality. Lancet. 2009 July 11; 374(9684):113-

4.

3. Asaria P, Beaglehole R, Chisholm D, Gaziano TA, Horton R, Leeder S, Lim SS, Mathers C,

Reddy S, Strong K, Voute J. Chronic Disease Prevention: The Importance of Calls to Action.

International Journal of Epidemiology. 2009 Mar 2; e-pub ahead of publication. Letter.

Thesis

1. Gaziano TA. Light-to-moderate alcohol consumption and mortality in the Physicians' Health

Study enrollment cohort. Boston: HMS; 1996.

Abstracts, Poster Presentations and Exhibits Presented at Professional Meetings

1. Abrahams-Gessel S, Denman CA, Montano CM, Gaziano TA, Levitt N, Rivera-Andrade A,

Carrasco DM, Zulu J, Khanam MA, Puoane T. Training and field work experiences of

Community Health Workers conducting non-invasive, population-based screening for

Cardiovascular disease (CVD) in four communities in Low and Middle-Income Settings.

American Public Health Association (APHA) Annual Meeting. Chicago, IL. 2015

2. Pandya A, Sy S, Gaziano TA. All Taking Some Or Some Taking None? Assessing Whether

Different Approaches for Modeling Drug Compliance Affect the Optimal Decision for Statin

Treatment Initiation. Society for Medical Decision Making 37th Annual Meeting (Session: Oral

Abstracts: Cost Effectiveness Of Cardiovascular Disease Interventions). St. Louis, MO. 2015.

3. Stephen Sy, Jose Peñalvo, Shafika Abrahams-Gessel, Sartaj Alam, Ankur Pandya, Dariush

Mozaffarian, Thomas Gaziano. Changes in Food Prices Improve Cardiovascular Disease (CVD)

Outcomes. EPI|LIFESTYLE 2016 Scientific Sessions, Epidemiology and Prevention | Lifestyle

and Cardiometabolic Health. Phoenix, AZ. 2015

4. Jennifer Manne-Goehler, Livia Montana, Xavier Gomez-Olive, Julia Rohr, Ryan Wagner,

Chodziwadziwa Kabudula, Alisha Wade, Kathleen Kahn, Stephen Tollman, Lisa Berkman, Till

Barnighausen, Thomas Gaziano. Human Immunodeficiency Virus (HIV) Infection,

Antiretroviral Therapy (ART) Use and Access to Care for Diabetes and Hypertension in

Agincourt, South Africa. Open Forum Infectious Disease. 2016, 85`

5. Thiago Veiga Jardim, Sheridan Reiger, Stephen Tollman, F. Xavier Gomez-Olive, Alisha Wade,

Ryan Wagner, Thomas Gaziano. Management of Cardiovascular Disease in Sub-Saharan

Africa: Data From the HAALSI (Health and Aging in Africa: Longitudinal Studies of

INDEPTH Communities) Study. ACC Scientific Sessions, Washington, D.C. 2017

6. Thiago Veiga Jardim, Dariush Mozaffarian, Shafika Abrahams-Gessel, Stephen Sy, Yujin Lee,

Junxiu Liu, Yue Huang, Parke Wilde, Renata Micha, Thomas Gaziano. Cardiometabolic disease

costs associated with an unhealthy diet in the United States. AHA EPI Lifestyle 2018 Scientific

Sessions, New Orleans, LA. 2018